Andrew Blight

Chief Scientific Officer, Acorda Therapeutics.

Companies

Acorda TherapeuticsChief Scientific Officer Feb 9, 2006 to Mar 3, 2017¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAcorda Therapeutics, Chief Scientific Officer